Insider Selling: Robert Lavallee Sells 2,500 Shares of Hologic Stock (HOLX)
Hologic (NASDAQ:HOLX) CAO Robert Lavallee sold 2,500 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $20.33, for a total transaction of $50,825.00. Following the transaction, the chief accounting officer now directly owns 19,090 shares in the company. The transaction was disclosed in a filing with the SEC, which is available at this link.
A number of analysts have recently weighed in on HOLX shares. Analysts at TheStreet downgraded shares of Hologic (NASDAQ:HOLX) to a “hold” rating in a research note to investors on Tuesday. Separately, analysts at Raymond James downgraded shares of Hologic (NASDAQ:HOLX) from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday, September 11th. They now have a $23.00 price target on the stock. Finally, analysts at ISI Group raised their price target on shares of Hologic (NASDAQ:HOLX) from $22.50 to $25.00 in a research note to investors on Tuesday, August 6th. They now have a “buy” rating on the stock.
One analyst has rated the stock with a sell rating, six have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $23.92.
Shares of Hologic (NASDAQ:HOLX) traded up 0.78% during mid-day trading on Tuesday, hitting $20.67. 1,121,286 shares of the company’s stock traded hands. Hologic has a 1-year low of $18.46 and a 1-year high of $23.96. The stock has a 50-day moving average of $22.03 and a 200-day moving average of $21.30. The company’s market cap is $5.590 billion.
Hologic (NASDAQ:HOLX) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.38 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.37 by $0.01. The company had revenue of $626.10 million for the quarter, compared to the consensus estimate of $627.05 million. During the same quarter last year, the company posted $0.35 earnings per share. Hologic’s revenue was up 33.2% compared to the same quarter last year. On average, analysts predict that Hologic will post $1.48 earnings per share for the current fiscal year.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products to serving the healthcare needs of women.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.